标题
Antibody–drug conjugates – a perfect synergy
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 12, Issue 9, Pages 1191-1206
出版商
Informa Healthcare
发表日期
2012-06-01
DOI
10.1517/14712598.2012.693473
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mining human antibody repertoires
- (2014) Roger R. Beerli et al. mAbs
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Disulfide-Linked Antibody−Maytansinoid Conjugates: Optimization of In Vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage
- (2011) Brenda A. Kellogg et al. BIOCONJUGATE CHEMISTRY
- SNAP-Tag Technology Mediates Site Specific Conjugation of Antibody Fragments with a Photosensitizer and Improves Target Specific Phototoxicity in Tumor Cells
- (2011) Ahmad Fawzi Hussain et al. BIOCONJUGATE CHEMISTRY
- Selective Formation of Covalent Protein Heterodimers with an Unnatural Amino Acid
- (2011) Benjamin M. Hutchins et al. CHEMISTRY & BIOLOGY
- Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin
- (2011) A. D. Ricart CLINICAL CANCER RESEARCH
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Antibody Conjugate Therapeutics: Challenges and Potential
- (2011) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Brentuximab Vedotin (SGN-35)
- (2011) J. Katz et al. CLINICAL CANCER RESEARCH
- Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
- (2011) Marie-Luise Hütter et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer
- (2011) Howard A Burris EXPERT OPINION ON BIOLOGICAL THERAPY
- The development of pyrrolobenzodiazepines as antitumour agents
- (2011) John A Hartley EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Investigational antibody drug conjugates for solid tumors
- (2011) Puja Sapra et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody
- (2011) In Soo Shin et al. NUCLEAR MEDICINE AND BIOLOGY
- Bispecific digoxigenin-binding antibodies for targeted payload delivery
- (2011) S. Metz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components
- (2011) Franco Dosio et al. Toxins
- Ranking the Susceptibility of Disulfide Bonds in Human IgG1 Antibodies by Reduction, Differential Alkylation, and LC−MS Analysis
- (2010) Hongcheng Liu et al. ANALYTICAL CHEMISTRY
- Design and Application of Antibody Cysteine Variants
- (2010) Vladimir Voynov et al. BIOCONJUGATE CHEMISTRY
- Physicochemical Stability of the Antibody−Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation Processes
- (2010) Aditya A. Wakankar et al. BIOCONJUGATE CHEMISTRY
- Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
- (2010) C. Zahnd et al. CANCER RESEARCH
- Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
- (2010) Y. V. Kovtun et al. CANCER RESEARCH
- Inotuzumab ozogamicin as novel therapy in lymphomas
- (2010) Bryan Y Wong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy
- (2010) Massimo Breccia et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Investigational antibody-drug conjugates for hematological malignancies
- (2010) Andrew G Polson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells
- (2010) Stephen M Ansell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Neonatal Fc Receptor: From Immunity to Therapeutics
- (2010) Timothy T. Kuo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor
- (2010) Arehalli S. Manjappa et al. JOURNAL OF CONTROLLED RELEASE
- Industrialization of mAb production technology: The bioprocessing industry at a crossroads
- (2010) Brian Kelley mAbs
- Have we overestimated the benefit of human(ized) antibodies?
- (2010) Daniel R. Getts et al. mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
- (2009) Laurent Ducry et al. BIOCONJUGATE CHEMISTRY
- Antibody-Drug Conjugate Targets
- (2009) B. Teicher CURRENT CANCER DRUG TARGETS
- The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics
- (2009) Jan Terje Andersen et al. Drug Metabolism and Pharmacokinetics
- A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
- (2009) M. M. Schmidt et al. MOLECULAR CANCER THERAPEUTICS
- A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution
- (2009) Fares Al-Ejeh et al. NUCLEAR MEDICINE AND BIOLOGY
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
- (2008) Greg M. Thurber et al. ADVANCED DRUG DELIVERY REVIEWS
- Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass
- (2008) Thomas M. Dillon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs
- (2008) Jagath R. Junutula et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index
- (2008) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
- An engineered selenocysteine defines a unique class of antibody derivatives
- (2008) T. Hofer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started